“Azacitidine Nanoemulsion Formulation and Characterization for the Tumor Treatment Suppressor Genes Activity in Myeloid Leukemia Cell Lines” (2025) Asian Journal of Pharmaceutics (AJP), 19(3). doi:10.22377/ajp.v19i3.6820.